Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 12 studies | 37% ± 13% | |
GABAergic neuron | 4 studies | 29% ± 9% | |
glutamatergic neuron | 3 studies | 32% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 24% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 3331.58 | 2547 / 2642 | 92% | 34.41 | 652 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.81 | 1 / 1 |
prostate | 12% | 40.11 | 30 / 245 | 71% | 4.67 | 358 / 502 |
esophagus | 38% | 566.27 | 555 / 1445 | 41% | 4.19 | 75 / 183 |
skin | 70% | 582.93 | 1271 / 1809 | 9% | 0.39 | 41 / 472 |
uterus | 12% | 65.54 | 21 / 170 | 53% | 4.45 | 241 / 459 |
bladder | 5% | 11.00 | 1 / 21 | 38% | 3.41 | 193 / 504 |
ovary | 0% | 0 | 0 / 180 | 41% | 2.13 | 176 / 430 |
tonsil | 0% | 0 | 0 / 0 | 38% | 4.04 | 17 / 45 |
liver | 2% | 6.96 | 4 / 226 | 36% | 5.11 | 146 / 406 |
breast | 1% | 3.24 | 5 / 459 | 26% | 1.72 | 293 / 1118 |
lung | 0% | 0 | 0 / 578 | 22% | 1.41 | 252 / 1155 |
eye | 0% | 0 | 0 / 0 | 10% | 0.51 | 8 / 80 |
spleen | 8% | 23.74 | 19 / 241 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 4% | 0.57 | 7 / 178 |
adrenal gland | 0% | 0 | 0 / 258 | 3% | 0.17 | 8 / 230 |
stomach | 1% | 1.09 | 2 / 359 | 2% | 0.09 | 7 / 286 |
intestine | 0% | 0 | 0 / 966 | 2% | 0.11 | 10 / 527 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.05 | 6 / 901 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.02 | 3 / 605 |
heart | 0% | 0.51 | 2 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.22 | 1 / 929 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.52 | 1 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.18 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006865 | Biological process | amino acid transport |
GO_0015718 | Biological process | monocarboxylic acid transport |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0015734 | Biological process | taurine transmembrane transport |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0003333 | Biological process | amino acid transmembrane transport |
GO_0051936 | Biological process | gamma-aminobutyric acid reuptake |
GO_0042995 | Cellular component | cell projection |
GO_0098982 | Cellular component | GABA-ergic synapse |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0016597 | Molecular function | amino acid binding |
GO_0005369 | Molecular function | taurine:sodium symporter activity |
GO_0008028 | Molecular function | monocarboxylic acid transmembrane transporter activity |
GO_0005332 | Molecular function | gamma-aminobutyric acid:sodium:chloride symporter activity |
Gene name | SLC6A11 |
Protein name | Sodium- and chloride-dependent GABA transporter 3 (GAT-3) (Solute carrier family 6 member 11) |
Synonyms | GABT3 GAT3 |
Description | FUNCTION: Mediates sodium- and chloride-dependent transport of gamma-aminobutyric acid (GABA) . Can also mediate transport of beta-alanine and to a lower extent that of taurine and hypotaurine (By similarity). . |
Accessions | P48066 ENST00000454147.1 [P48066-2] ENST00000254488.7 [P48066-1] |